Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 88Completed 66Active not recruiting 53Terminated 26Withdrawn 14Not yet recruiting 9Unknown 7Suspended 2No longer available 2Approved for marketing 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Breast 4Lymphoid 3Head & Neck 3Tumor-Agnostic 2Other hematologic neoplasm 2Genitourinary 2Dermatologic 2Thoracic 1Sarcoma 1Plasma cell 1Gynecologic 1CNS 1

Conditions

Urinary Bladder Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 5Nivolumab 3Biopsy 3Magnetic Resonance Spectroscopy 2Docetaxel 2talazoparib 1romidepsin 1pembrolizumab 1olaparib 1imisopasem manganese 1gallium 68 PSMA-11 1durvalumab 1cabozantinib 1balstilimab 1aldesleukin 1abivertinib 1abiraterone 1abarelix 1Watchful Waiting 1Standard of Care 1Radiosurgery 1Practice Guidelines as Topic 1Pluvicto 1Palliative Care 1Paclitaxel 1Observation 1N-acetylcochinol-O-phosphate 1Mental Status and Dementia Tests 1Menogaril 1Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Magnetic Resonance Spectroscopy × Genitourinary × Clear all
NCT03375307 2026-06-05

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes

National Cancer Institute (NCI)

Phase 2 Suspended
60 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03575611 2026-04-15

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

M.D. Anderson Cancer Center

Phase 2 Suspended
123 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡